Common Stock, Shares, Outstanding of REGENXBIO Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
REGENXBIO Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • REGENXBIO Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 50,892,000, a 2.7% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

REGENXBIO Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 50,892,000 +1,343,000 +2.7% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 50,619,000 +1,085,000 +2.2% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 50,389,000 +1,072,000 +2.2% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 50,117,000 +1,074,000 +2.2% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 49,549,000 +5,503,000 +12% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 49,534,000 +5,543,000 +13% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 49,317,000 +5,696,000 +13% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 49,043,000 +5,578,000 +13% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 44,046,000 +747,000 +1.7% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 43,991,000 +699,000 +1.6% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 43,621,000 +450,000 +1% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 43,465,000 +483,000 +1.1% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 43,299,000 +468,000 +1.1% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 43,292,000 +540,000 +1.3% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 43,171,000 +616,000 +1.4% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 42,982,000 +477,000 +1.1% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 42,831,000 +5,355,000 +14% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 42,752,000 +5,348,000 +14% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 42,555,000 +5,264,000 +14% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 42,505,000 +5,315,000 +14% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 37,476,000 +484,000 +1.3% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 37,404,000 +564,000 +1.5% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 37,291,000 +539,000 +1.5% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 37,190,000 +579,000 +1.6% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 36,992,000 +872,000 +2.4% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 36,840,000 +1,136,000 +3.2% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 36,752,000 +4,477,000 +14% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 36,611,000 +4,711,000 +15% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 36,120,000 +4,825,000 +15% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 35,704,000 +4,595,000 +15% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 32,275,000 +1,422,000 +4.6% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 31,900,000 +1,656,000 +5.5% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 31,295,000 +4,818,000 +18% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 31,109,000 +4,634,000 +18% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 30,853,000 +4,390,000 +17% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 30,244,000 +3,906,000 +15% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 26,477,000 +164,000 +0.62% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q3 2016 26,475,000 +169,000 +0.64% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 26,463,000 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 26,338,000 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 26,313,000 +23,668,000 +895% 31 Dec 2015 10-K 07 Mar 2017 2016 FY
Q3 2015 26,306,000 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q4 2014 2,645,000 31 Dec 2014 10-K 03 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.